Recombinant Human ABCB5 Protein，His

ABCB5, a member of the ATP-binding cassette (ABC) transporter family, has garnered significant attention in biomedical research due to its implications in multidrug resistance, particularly in cancer therapy. This protein functions primarily as a pump that expels various drugs and toxins from cells, thereby contributing to the survival of cancer cells in the presence of chemotherapeutic agents. Overexpression of ABCB5 has been identified in various malignancies, including melanoma and colorectal cancer, where it plays a critical role in maintaining stem cell-like properties and promoting tumorigenesis. Recent studies have focused on understanding the structure and function of recombinant ABCB5 proteins to elucidate their mechanisms of action and to identify potential inhibitors that could reverse drug resistance. The development of recombinant ABCB5 proteins allows researchers to explore their functional dynamics in vitro and in vivo, paving the way for novel therapeutic strategies aimed at overcoming drug resistance in cancer treatments. By targeting ABCB5, there is potential not only to enhance the efficacy of existing chemotherapy regimens but also to improve patient outcomes in drug-resistant cancers, marking a significant step forward in personalized medicine. This research area continues to evolve as scientists seek to unravel the complex interactions between ABCB5 and other molecular pathways involved in cancer progression and drug resistance.